Company Profile

Apimeds Pharmaceuticals US, Inc., is a clinical-stage biopharmaceutical company. The Company is engaged in developing Apitox, an intradermally administered bee venom-based toxin. It is focused on developing Apitox in the treatment of inflammatory conditions in the United States, specifically osteoarthritis and multiple sclerosis. Its subsidiary, MindWave Innovations Inc, is a provider of institutional digital asset treasury (DAT) solutions.

Employees

Sector

Biotechnology & Medical Research

More about the company

Quotes

Date	Price	Change	Volume
12/11/26	US$2.300	-2.54%	9,337
11/11/26	US$2.360	-12.27%	63,967
10/11/26	US$2.690	-0.37%	11,603
09/11/26	US$2.700	-0.18%	38,111
06/11/26	US$2.705	-0.92%	16,685

Delayed Quote NYSE

More quotes

Delayed NYSE 14:33:40 12/11/2026 GMT			5-day change	1st Jan Change
2.300 ^USD	-2.54%		-15.75%	-85.98%

10-13	Mindwave Innovations Inc. Usa to Begin Nila Token Trading on Pionex	CI
10-10	MindWave Innovations Inc. USA Secures Three Client Agreements to Build and Operate MindChain Networks Across Climate Finance, Sports Media and Insurance	CI

Markets		Quality
NYSE	APUS	Delayed
CBOE	APUS	Real-time

10-13	Mindwave Innovations Inc. Usa to Begin Nila Token Trading on Pionex	CI
10-10	MindWave Innovations Inc. USA Secures Three Client Agreements to Build and Operate MindChain Networks Across Climate Finance, Sports Media and Insurance	CI
10-05	Mindwave Innovations Inc. Usa Signs Agreement with Blockassure Inc. to Build and Operate Assurechain, an End-To-End Insurance and Reinsurance Network	CI
10-01	Apimeds Pharmaceuticals US, Inc. Announces Change of Chief Financial Officer	CI
09-29	Mindwave Innovations Inc. Enters 12-Month Software Development and Technology Services Agreement with Flash Sports & Media Holdings, Inc. to Build and Operate Flashchain	CI
09-24	Top Midday Gainers	MT
09-24	MindWave Innovations Inc. Signs Agreement With AQUAE Holdings Pte. Ltd. To Build And Operate AQUAEChain, A Platform For Insured ALCI Credits	CI
09-11	Apimeds Pharmaceuticals US, Inc. Announces Appointment of Sungjoon Chae as Director	CI
08-06	Apimeds Pharmaceuticals US, Inc. Announces Appointment of Christopher Kim as Chief Scientific Officer, Effective August 5, 2026	CI
08-03	MindWave Innovations Inc. Announces NILA Token Availability To Eligible U.S. Users On Webot	CI
07-28	MindWave Innovations Inc. Announces MindChain And NILA Token Launch	CI
05-05	Apimeds Pharmaceuticals US, Inc. Appoints Sungjoon Chae to Serve as Co-Chief Executive Officer, Effective May 4, 2026	CI
03-26	Apimeds Pharmaceuticals US Inc Vin Menon continues to serve as the company's chief executive officer	RE

10-05	MindWave Innovations Signs Agreement with US-Based BlockAssure to Build and Operate AssureChain, an End-to-End Insurance and Reinsurance Network	AQ
09-29	MindWave Innovations Expands U.S. Commercial Footprint with Second Agreement to Build and Operate FlashChain for New York-Based Flash Sports & Media	AQ
09-25	DarkHorse (NASDAQ: DRK) Strategic Partners Power Up AI Data Center Expansion Across TVA Region	AQ
09-25	Emerging Growth DRK GLND APUS GCTK Stocks in the News	AQ
09-24	MindWave Innovations Signs Agreement to Build and Operate AQUAEChain, a Platform for Insured ALCI Credits	AQ

Apimeds Pharmaceuticals US, Inc. Share Price

Stocks

APUS

US03771D2018

Biotechnology & Medical Research

Chart: Apimeds Pharmaceuticals US, Inc.

Latest news: Apimeds Pharmaceuticals US, Inc.

Press Releases: Apimeds Pharmaceuticals US, Inc.

Quotes and Performance

Price Extremes

Latest insider transactions

Bio Therapeutic Drugs

Company Profile

Quotes

1 day	-2.54%
1 week	-15.75%
Current month	-23.59%
1 month	-55.77%
3 months	-50.64%
6 months	-82.84%
Current year	-85.98%

1 week	2.2	2.75
1 month	2.2	4.91
Current year	1.51	59.7
1 year	1.51	59.7
3 years	1.51	59.7
5 years	1.51	59.7
10 years	1.51	59.7

Date	Insider	Type	Main position	Quantity	% Market Cap.
11/11/25	Carol O'Donnell	Free	Director	10,000	0.0795%
11/11/25	Ja-Kap Koo	Free	Director	10,000	0.0795%
11/11/25	Hankil Yoon	Free	Director	10,000	0.0795%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
APIMEDS PHARMACEUTICALS US, INC.	-2.54%	-15.75%	-	-	3.56M
WUXI APPTEC CO., LTD.	+1.10%	+1.03%	+62.53%	+70.47%	67.53B
ARGENX SE	-0.07%	+7.21%	+12.39%	+90.05%	60.74B
LONZA GROUP AG	-0.02%	-1.52%	+19.40%	+97.32%	55.66B
BEONE MEDICINES AG	+0.08%	+8.14%	+10.94%	+110.59%	47.97B
IQVIA HOLDINGS INC.	-2.34%	+1.94%	+22.25%	+39.43%	45.24B
REVOLUTION MEDICINES, INC.	-2.14%	+0.74%	+171.85%	+810.74%	39.08B
CELLTRION, INC.	+1.21%	+4.75%	+27.30%	+52.81%	35.34B
GENMAB A/S	-1.77%	-3.93%	+77.66%	+54.65%	33.45B
INSMED INCORPORATED	-2.64%	+8.78%	-39.14%	+395.02%	26.49B
Average	-0.87%	+0.51%	+40.58%	+191.23%	41B
Weighted average by Cap.	-0.46%	+2.88%	+40.90%	+166.65%